fingolimod has been researched along with everolimus in 1 studies
| Studies (fingolimod) | Trials (fingolimod) | Recent Studies (post-2010) (fingolimod) | Studies (everolimus) | Trials (everolimus) | Recent Studies (post-2010) (everolimus) |
|---|---|---|---|---|---|
| 65 | 0 | 51 | 5,631 | 1,289 | 4,579 |
| Protein | Taxonomy | fingolimod (IC50) | everolimus (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 2 | |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0022 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angst, D; Bassilana, F; Beerli, C; Berst, F; Bollbuck, B; Bruns, C; Buehlmayer, P; Hersperger, R; Janser, P; Oberer, L; Pally, C; Quancard, J; Streiff, M | 1 |
1 other study(ies) available for fingolimod and everolimus
| Article | Year |
|---|---|
An oral sphingosine 1-phosphate receptor 1 (S1P(1)) antagonist prodrug with efficacy in vivo: discovery, synthesis, and evaluation.
Topics: Administration, Oral; Aminobutyrates; Animals; Heart Transplantation; Lymphocytes; Magnetic Resonance Spectroscopy; Male; Molecular Structure; Prodrugs; Rats; Rats, Inbred Lew; Receptors, Lysosphingolipid; Sulfonamides | 2012 |